Jiang, Jianhao,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2024) -coding
RNAs (
lncRNAs) acting as competing endogenous
RNAs (ce
RNAs) continues to grow, encompassing a broad
Gilyazova, Irina,
Gimalova, Galiya,
Nizamova, Aigul,
Nizamova, Aigul,
Ishbulatova, Ekaterina,
Pavlov, Valentin,
Khusnutdinova, Elza (2024) , regulatory mechanisms, and therapeutic potential of nc
RNAs including microRNA (miRNA), long ncRNA (
lncYuan, Yue,
Han, Xuejie,
Zhao, Xinbo,
Zhang, Haiyu,
Vinograd, Asiia,
Bi, Xin,
Duan, Xiaoxu,
Cao, Yukai,
Gao, Qiang,
Song, Jia,
Sheng, Li,
Li, Yue (2024) -coding
RNAs (
lncRNAs), involve in the progress of multiple cardiovascular diseases. However, their potential
) and long non-coding
RNAs (
lncRNAs), as key regulators in the pathogenesis of hypertension. These nc
RNAs, and MEG3
lncRNAs in patients with type 2 diabetes and metabolic parameters, as well as the risk
of long noncoding
RNAs and micro
RNAs from transposons, changes in the expression of which are observed
Markelov, V.A.,
Korytina, G.F.,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N. Sh. (2024) regulators, such as long noncoding
RNAs (
lncRNAs). To assess the contribution of genes involved in key
Markelov, V.A.,
Korytina, G.F,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N Sh (2024) regulators, such as long noncoding
RNAs (
lncRNAs). To assess the contribution of genes involved in key